Cart
sales@molnova.com
ROC-325
CAS No. 1859141-26-6
ROC-325( ROC 325 | ROC325 )
Catalog No. M12869 CAS No. 1859141-26-6
ROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 74 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 50MG | 246 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 548 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameROC-325
-
NoteResearch use only, not for human use.
-
Brief DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
-
DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy; exhibits superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in different cancer cell lines, including accumulation of autophagosomes with undegraded cargo, lysosomal deacidification, p62 stabilization, and disruption of autophagic flux; antagonizes RCC growth and survival in an ATG5/7-dependent manner, induces apoptosis and exhibited favorable selectivity; significantly more effective at inhibiting tumor progression than HCQ, and inhibited autophagy in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsROC 325 | ROC325
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1859141-26-6
-
Formula Weight503.061
-
Molecular FormulaC28H27ClN4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO : 32 mg/mL 63.61 mM; H2O : < 0.1 mg/mL
-
SMILESO=C1C2=C(C(C)=CC=C2NCCN(C)CCNC3=C(C=CC(Cl)=C4)C4=NC=C3)SC5=CC=CC=C51
-
Chemical Name1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carew JS, et al. Clin Cancer Res. 2017 Jun 1;23(11):2869-2879.
2. Carew JS, et al. Autophagy. 2017 Apr 3;13(4):765-766.
molnova catalog
related products
-
Mefloquine hydrochlo...
A quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine; inhibits autophagy and has been recognized as a potential target for cancer therapy.
-
Indophagolin
Indophagolin is a potent, indoline-containing autophagy inhibitor with IC50 of 140 nM.?
-
SMER-28
A small-molecule enhancer/inducer of Autophagy; decreases the levels of Aβ peptide (EC50=10 uM) and APP-CTF (EC50 of 20 uM) in a γ-secretase-independent manner in primary neuronal cultures, Atg5, Beclin1 and Ulk1 are shown to be involved in the degradation of Aβ and APP-CTF.
